Analysis Cancer Immunology and Therapy

Image

Analysis Cancer Immunology and Therapy

Journal of cancer immunology and Therapy deals with research from all related fields to the Cancer Immunology & Therapy which utilises the immune system as a treatment for cancer. Cancer immunology and therapy deals with Cancer Discovery, Cancer Epidemiology, Biomarkers & Prevention, Cancer Immunology Research, Cancer Surgery, Advances in Cancer Prevention, Breast Cancer, Cancer Biology, Cancer Treatment, Cancer Management and Research, Integrative Cancer Therapies, Clinical cancer immunology and therapy. and Articles such as research papers, review articles, commentaries and short communications leading to the development of Cancer Immunology and Therapy.

Cancer immunotherapy is a therapy used to treat cancer patients that involves or uses components of the immune system. Some cancer immunotherapies consist of antibodies that bind to, and inhibit the function of, proteins expressed by cancer cells. Other cancer immunotherapies include vaccines and T cell infusions.

In the past years , our knowledge about the relationship between cancer and the immune system has increased considerably. Recent years' success of cancer immunotherapy including monoclonal antibodies , cancer vaccines, adoptive cancer therapy and the immune checkpoint therapy has revolutionized traditional cancer treatment. However, challenges still exist in this field. Personalized combination therapies via new techniques will be the next promising strategies for the future cancer treatment direction.

How to submit:

Manuscripts can be submitted through the Editorial Office  at Email: cancerimmunol@eclinicalsci.com 

How we work:

We are using Editor Manager System for easy online tracking and managing of the manuscript processing. Each article undergoes a peer review process under the aegis of an assigned Editor. To be acceptable for publication, an article should be positively considered by two individual reviewers followed by the Editor’s consent.

  • After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
  • A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
  • Manuscript will be published within 7days of acceptance.

 

Regards
Shelley Brown
Editorial Team
Journal of Cancer Immunology and Therapy
Email: cancerimmunol@eclinicalsci.com 
WhatsApp: +1-97-333-4405